Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v2-FR
Language French French
Date Updated 2021-02-11 2021-01-28
Drug Identification Number 02248861 02248861
Brand name TEVA-TOPIRAMATE TEVA-TOPIRAMATE
Common or Proper name TOPIRAMATE 100MG TAB TOPIRAMATE 100MG TAB
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients TOPIRAMATE TOPIRAMATE
Strength(s) 100MG 100MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 60 60
ATC code N03AX N03AX
ATC description ANTIEPILEPTICS ANTIEPILEPTICS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-01-26 2021-01-26
Estimated end date 2021-02-28 2021-02-28
Actual end date 2021-02-10
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments